Alpha-2-delta ligand to treat lower urinary tract symptoms
Disclosed is a use of a combination of an alpha-2-delta ligand with a compound selected from i) a PDEV inhibitory compound; or ii) a muscarinic antagonist; or pharmaceutically acceptable salts or solvates thereof, for the manufacture of a medicament for the treatment of lower urinary tract symptoms...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Disclosed is a use of a combination of an alpha-2-delta ligand with a compound selected from i) a PDEV inhibitory compound; or ii) a muscarinic antagonist; or pharmaceutically acceptable salts or solvates thereof, for the manufacture of a medicament for the treatment of lower urinary tract symptoms (LUTS) associated with over active bladder (OAB) and/or benign prostatic hyperplasia (BPH). (62) Divided Out of 539972 |
---|